Under the agreement, DCH Auriga Hong Kong Ltd. will leverage its specialty cold chain expertise and unique healthcare-dedicated infrastructure to provide Ultra Low Temperature storage and distribution for the safe and timely supply of the COVID-19 vaccine.
Tim Collins, the CEO of DCH Auriga said, "We are honoured to support this vital vaccination program and play a part in protecting the health and well-being of our communities. As long-time partners of the public health system and specialists in cold chain distribution for the healthcare industry, we are well experienced in handling Ultra Low temperature requirements with highly trained staff and robust quality assurance protocols. We are confident in our ability to deliver this vaccine safely and securely, in full accordance with the directives of the Government and Department of Health."
DCH Auriga
DCH Auriga, a subsidiary of Dah Chong Hong Holdings Limited, is an Asia-based market management provider specialising in healthcare. Offering comprehensive commercial and logistics solutions, DCH Auriga partners with the world's leading healthcare companies to distribute pharmaceuticals, medical devices, surgical equipment, diagnostics and OTC products for more than 500 brands into hospitals, pharmacies and specialty stores across Asia. DCH Auriga has operations in Hong Kong, Macao, mainland China, Singapore, Malaysia, Indonesia, Thailand and the Philippines.
For more details, please visit www.dchauriga.com.
Dah Chong Hong Holdings, an indirect wholly owned subsidiary of CITIC Limited (stock code: 0267.HK), is an integrated trading and distribution company operating in Asia, supported by an extensive logistics network. DCH is a leading distributor and dealer of motor vehicles in Greater China as well as a provider of a full range of associated services. DCH's consumer business comprises the manufacture and distribution of food, healthcare, electrical appliances, beauty and lifestyle products. DCH employs over 16,500 staff with operations in 12 Asian markets.
For more details, please visit www.dch.com.hk.
Media Enquires:
DCH Communications | (852) 2768 2017 | dchcommunications@dch-holdings.com
Copyright 2021 ACN Newswire. All rights reserved. www.acnnewswire.com
source http://www.acnnewswire.com/press-release/english/64244/